La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
ApicHope Pharmaceutical Dividende
Dividende contrôle des critères 3/6
ApicHope Pharmaceutical is a dividend paying company with a current yield of 1.32% that is well covered by earnings.
Informations clés
1.3%
Rendement du dividende
53%
Ratio de distribution
| Rendement moyen de l'industrie | 1.9% |
| Prochaine date de paiement du dividende | n/a |
| Date ex-dividende | n/a |
| Dividende par action | CN¥0.210 |
| Résultat par action | CN¥0.39 |
| Prévisions de rendement du dividende à 3 ans | 0% |
Mises à jour récentes des dividendes
Recent updates
Does ApicHope Pharmaceutical (SZSE:300723) Have A Healthy Balance Sheet?
Jun 27
ApicHope Pharmaceutical (SZSE:300723) Is Paying Out A Larger Dividend Than Last Year
May 27ApicHope Pharmaceutical's (SZSE:300723) Shareholders Have More To Worry About Than Only Soft Earnings
May 03Bearish: Analysts Just Cut Their ApicHope Pharmaceutical Co., Ltd (SZSE:300723) Revenue and EPS estimates
May 02ApicHope Pharmaceutical (SZSE:300723) Has A Pretty Healthy Balance Sheet
Mar 15Market Participants Recognise ApicHope Pharmaceutical Co., Ltd's (SZSE:300723) Earnings
Feb 27Stabilité et croissance des paiements
Récupération des données sur les dividendes
Dividende stable: Whilst dividend payments have been stable, 300723 has been paying a dividend for less than 10 years.
Dividende croissant: 300723's dividend payments have increased, but the company has only paid a dividend for 6 years.
Rendement des dividendes par rapport au marché
| ApicHope Pharmaceutical Rendement des dividendes par rapport au marché |
|---|
| Segment | Rendement du dividende |
|---|---|
| Entreprise (300723) | 1.3% |
| 25% du marché (CN) | 0.7% |
| 25% du marché (CN) | 2.6% |
| Moyenne du secteur (Pharmaceuticals) | 1.9% |
| Prévisions des analystes dans 3 ans (300723) | 0% |
Dividende notable: 300723's dividend (1.32%) is higher than the bottom 25% of dividend payers in the CN market (0.73%).
Dividende élevé: 300723's dividend (1.32%) is low compared to the top 25% of dividend payers in the CN market (2.63%).
Bénéfice distribué aux actionnaires
Couverture des revenus: With its reasonable payout ratio (53%), 300723's dividend payments are covered by earnings.
Paiement en espèces aux actionnaires
Couverture des flux de trésorerie: With its reasonable cash payout ratio (70%), 300723's dividend payments are covered by cash flows.